While teams had similar risk things and initial eye problems, the HBOT group, In spite of remaining older with shorter symptom duration, showed drastically enhanced remaining eyesight after changing for age, sex, and symptom length. The review implies adding HBOT to standard care increases ultimate Visible outcomes for CRAO, advocating its use in t